Filing Details
- Accession Number:
- 0001140361-14-005760
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-11 11:19:06
- Reporting Period:
- 2014-02-07
- Filing Date:
- 2014-02-11
- Accepted Time:
- 2014-02-11 11:19:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1030206 | Vascular Solutions Inc | VASC | Surgical & Medical Instruments & Apparatus (3841) | 411859679 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1448192 | William Rutstein | C/O Vascular Solutions, Inc. 6464 Sycamore Court North Minneapolis MN 55316 | Sr. Vp Of Worldwide Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-02-07 | 16,116 | $23.88 | 50,091 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-10 | 11,666 | $23.70 | 38,425 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 66,207 | Direct |
Footnotes
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $23.80 to $24.12 per share. Mr. Rutstein has provided to the Company, and upon request, will provide any security holder of the company or the SEC staff information regarding the number of shares sold at each price within that range.
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $23.6225 to $23.725 per share. Mr. Rutstein has provided to the Company, and upon request, will provide any security holder of the company or the SEC staff information regarding the number of shares sold at each price within that range.
Billionaire Hedge Funds
